Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Ejhaem|December 18, 2024
The UK consensus supporting effective introduction of novel treatments for multiple myeloma in the National Health ServiceRakesh Popat, Supratik Basu, Sarah Henshaw, et al.
Ejhaem|May 18, 2026
European Recommendations for Transitioning the Care of Patients With Multiple Myeloma Treated With B-Cell Maturation Antigen Bispecific Antibodies From Academic Hospitals to Community-Based Centers and for Outpatient Step-Up DosingMaría-Victoria Mateos, Elena Zamagni, Massimo Gentile, et al.
British Journal of Haematology|June 15, 2005
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myelomaHeather E Oakervee, Rakesh Popat, Nicola Curry, et al.
The Lancet. Haematology|November 16, 2016
Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trialRakesh Popat, Sarah R Brown, Louise Flanagan, et al.
Blood Advances|July 19, 2023
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysisGemma Reynolds, Edward R Scheffer Cliff, Ghulam Rehman Mohyuddin, et al.
International Journal of Hematologic Oncology|November 29, 2021
A Phase I trial of talazoparib in patients with advanced hematologic malignanciesAjay K Gopal, Rakesh Popat, Ryan J Mattison, et al.
British Journal of Haematology|February 3, 2009
Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myelomaRakesh Popat, Heather Oakervee, Catherine Williams, et al.
Blood Cancer Journal|March 16, 2023
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemicJonathan Carmichael, Frances Seymour, Graham McIlroy, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2025
Ranking the Importance of Prognostic Factors for Relapsed/Refractory Multiple Myeloma: International Physician Panel Consensus Following a Systematic Literature ReviewShaji Kumar, Xavier Leleu, Katja C Weisel, et al.
Blood Cancer Journal|November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosisRicha Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Pageof 9